secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001570562-22-000146
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus extends $50M undrawn tranche availability to Dec 2023
------------------------------------------------------------

- Second $50M tranche under $125M term loan facility now available until Dec 31, 2023 (extended from Dec 31, 2022).
- Paid $500K amendment fee; all other terms unchanged (3-month LIBOR +8.5%, interest-only first 36 months).
- First $75M tranche fully drawn in 2021; company expects existing cash to fund operations through breakeven.
- CEO cites market share gains and millennial demographic focus; Pharmakon continues to support the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000146/0001570562-22-000146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000146/eols-20221205.htm
  HTML page:      https://secwatch.observer/filing/0001570562-22-000146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer